Levophed

Norepinephrine, the active ingredient in Levophed, is a sympathomimetic presented as an injection for intravenous use. It is employed to raise blood pressure in acute hypotensive states, support circulation during septic shock, and improve perfusion in cardiac arrest patients.

GNH USA supplies Levophed as a licensed, GDP‑compliant international pharmaceutical product, providing the medication to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under GMP conditions.

Levophed (norepinephrine) is used in critical‑care settings to manage severe circulatory failure. - Hypotension: restores adequate arterial pressure in acute low‑blood‑pressure states. - Septic shock: improves circulatory stability during severe infection. - Cardiac arrest: supports perfusion while resuscitation efforts are ongoing.

Levophed may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache - Tachycardia - Nausea

Serious or Rare Side Effects: - Severe hypertension - Cardiac ischemia - Tissue necrosis at the infusion site

When using Levophed, careful monitoring and specific safety measures are essential. - Monitor blood pressure: continuous arterial line monitoring is recommended. - Assess cardiac rhythm: watch for arrhythmias during infusion. - Adjust infusion rate: titrate to achieve target mean arterial pressure. - Avoid extravasation: prefer central venous access to reduce local tissue injury. - Use with caution in coronary artery disease: increased risk of myocardial ischemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levophed can interact with several drug classes; awareness of major and moderate interactions helps guide safe use.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Beta‑blockers: can blunt the intended increase in cardiac output. - Tricyclic antidepressants: may potentiate vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Vasodilators: may require higher norepinephrine doses to maintain pressure. - Diuretics: can alter intravascular volume and affect response.